Persistent Systems Ltd. moves to reshape its capital structure

The USD 1,250 million resolution is far larger than Persistent Systems’ cash balance: approximately 9.58x current cash. The board authorization corresponds to roughly Rs 10,300 Crores, while consolidated cash and cash equivalents were Rs 1,074.9 Crores in Q1 FY27, the latest quarterly balance available ^{[1] [2]}.

Against acquisition spending, a precise 24-month cumulative comparison cannot be established from the disclosed figures. The cited acquisition coverage identifies transactions but does not provide consideration paid for each completed acquisition or a consolidated 24-month total. In particular, the Nagarro transaction was reported at approximately USD 1.3 billion, but it was an announced deal expected to close by March 2027—not consideration already paid ^[3]. It therefore should not be included in a “paid over the last 24 months” total.

The analytical takeaway is that the resolution represents a step-change in potential capital deployment, not simply a replenishment of the cash used for recent bolt-on acquisitions. It is close in scale to the proposed Nagarro purchase and substantially exceeds the company’s current cash resources, implying that any full utilization would require external capital—through equity, debt, or a combination—rather than internally funded acquisitions alone. Persistent had no consolidated total debt in the latest reported data ^[4], which makes the financing structure and potential dilution particularly important, but the resolution itself does not specify how much would ultimately be raised or deployed.

Verdict: Persistent Systems is currently in a net-cash, debt-free position on a consolidated basis. In Q1 FY27, reported debt-to-equity and gross debt-to-equity were 0.00x, while net debt-to-equity was -0.14x, indicating that cash exceeded debt. ^{[5] [6] [7]}

Current balance-sheet profile

• Total debt: Rs 0 Crores on a consolidated basis in Q1 FY27. ^[8]
• Cash and equivalents: Rs 1,074.9 Crores on a latest consolidated basis. ^[2]
• Net debt: negative Rs 1,074.9 Crores, i.e., net cash of Rs 1,074.9 Crores. ^[9]
• Liquidity indicators: current ratio was 2.43x and interest coverage was 26.34x in Q1 FY27. ^{[10] [11]}

The standalone position is similar: debt-to-equity was 0.00x, gross debt-to-equity was 0.00x, and net debt-to-equity was -0.11x in Q1 FY27. ^{[12] [13] [14]}

How the USD 1,250 million authorization fits

The board approved:

• long-term debt financing of up to USD 1,250 million through ECBs, NCDs or similar instruments;
• equity or equity-linked fundraising of up to USD 450 million; and
• a combined ceiling of USD 1,250 million across the debt and equity-related routes, subject to shareholder and regulatory approvals. ^[15]

This is an authorization ceiling, not reported borrowing or an executed capital raise. Therefore, it does not change the current debt-to-equity profile. The immediate interpretation is that the company is creating financing optionality from a clean balance sheet rather than repairing an existing leverage problem.

However, the alignment with capital-allocation policy is only conditional. The board filing describes the proposal as long-term debt financing but does not state:

• a target or maximum leverage ratio;
• a minimum cash or liquidity buffer;
• the intended debt-equity mix within the USD 1,250 million envelope; or
• the specific use of proceeds. ^[15]

Accordingly, the proposal is directionally consistent with a conservative leverage-and-liquidity policy only if drawdowns are staged, debt remains within an internally defined leverage ceiling, and the existing cash buffer is preserved. If the company ultimately uses most of the envelope as debt, the balance sheet would move materially away from its present zero-debt/net-cash position; if equity or convertibles are used, leverage would rise less but dilution or future conversion would become the relevant trade-off.

Analyst read: the key issue is not today’s leverage—it is whether management discloses the intended financing mix, deployment timetable, leverage guardrails and post-transaction liquidity floor. Without those details, the USD 1,250 million limit should be viewed as strategic funding capacity rather than evidence of an already changing capital structure.

Persistent’s USD 1,250 million approval is large in headline terms, but it should not be compared with a USD 1,250 million equity issue. The approval permits up to USD 1,250 million of combined financing, including ECBs, NCDs and other debt, while the equity-linked component—QIP, FCCB, preferential issue or similar instruments—is capped at USD 450 million. The overall financing remains subject to shareholder and regulatory approvals and may be raised in tranches. ^[15]

The relevant equity comparison is therefore USD 450 million, equal to 36.00% of the headline envelope. That is approximately 18.18% below Coforge’s USD 550 million QIP proposal, while Persistent’s total financing envelope is approximately 2.27 times that proposal. These are derived comparisons from the disclosed limits. ^{[15] [16]}

Persistent Systems

• Frequency: One board-level financing approval is evidenced; no completed QIP, ADR or GDR issuance is evidenced in the cited record for the period.
• Size: USD 1,250 million aggregate financing capacity; USD 450 million maximum equity-linked component. ^[15]
• Purpose and interpretation: The filing describes the purpose as long-term financing rather than earmarking the funds specifically for a named acquisition. Separately, management said future inorganic growth would comprise targeted, capability-led acquisitions, with large acquisitions expected to be selective. ^[17]
• Analyst read: This is better viewed as a large financing option pool or acquisition firepower, not as a committed equity raise. The headline amount overstates the directly comparable dilution capacity.

Coforge

• Frequency: Coforge provides the clearest peer example of repeated capital-markets use around acquisitions: it raised Rs 2,240 Crores through a QIP for the Cigniti acquisition, and subsequently obtained approval for a further USD 550 million QIP for the Encora transaction. ^[16]
• Status: The later USD 550 million QIP was ultimately canceled after Coforge secured a USD 550 million syndicated loan. ^[18]
• Other equity funding: Coforge also allotted more than 9.37 Crores shares preferentially to Encora sellers; this was acquisition consideration, not a QIP or ADR/GDR issue. ^[19]
• Analyst read: Coforge’s pattern was more frequent but transaction-specific: one completed QIP and one subsequently abandoned QIP proposal within roughly the three-year window. Persistent’s potential equity capacity is slightly smaller than Coforge’s canceled USD 550 million proposal, but its aggregate debt-plus-equity authorization is substantially larger.

MphasiS

No qualifying QIP, ADR or GDR issuance used for inorganic expansion is reported in the cited record for the roughly September 2023–September 2026 window. Frequency and size are therefore not established, rather than zero.

Hexaware Technologies

No qualifying QIP, ADR or GDR issuance used for inorganic expansion is reported in the cited record for the same window. A peer frequency or size comparison cannot be established from the cited material.

Tata Elxsi

No qualifying QIP, ADR or GDR issuance used for inorganic expansion is reported in the cited record. The available evidence therefore does not support assigning a three-year issuance frequency or amount.

Tech Mahindra

No qualifying QIP, ADR or GDR issuance used for inorganic expansion is reported in the cited record. No comparable three-year capital-raising pattern can be quantified.

Capital-raising pattern

The evidence points to three conclusions:

• Scale: Persistent’s USD 1,250 million total authorization is unusually large relative to the USD 550 million QIP proposal seen at Coforge, but only USD 450 million is equity-linked.
• Frequency: Coforge is the only peer with a clearly evidenced repeated QIP cycle; Persistent has an approval but no evidenced completed issue.
• Instrument choice: No ADR/GDR issuance is documented for the named companies in the cited record. The identifiable pattern is QIP, debt financing and, in Coforge’s case, preferential equity—not ADR/GDR fundraising.

The main uncertainty is execution: Persistent has authorized capacity, not disclosed proceeds raised or a named acquisition funded.